Evidence map›Paper›PMID 39677784›Full record

ArticlebioRxiv : the preprint server for biology2024

PD-L1 expression is mediated by microRNA processing, Wnt/β-catenin signaling, and chemotherapy in Wilms tumor.

Kavita Desai, Patricia D B Tiburcio, Austin Warne, Arash Nabbi, Serena Zhou, Sean D Reiff, Matthew E Campbell, Kenneth S Chen

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Kavita DesaiDivision of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
Patricia D B TiburcioDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX.
Austin WarneDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX.
Arash NabbiPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Serena ZhouDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX.
Sean D ReiffDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX.
Matthew E CampbellDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX.
Kenneth S ChenDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX.ORCID 0000-0003-2304-4631

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Kathryn Ann O'Donnell · 2010 to 2026
$53.7M
University of Texas Southwestern Medical Center SPORE in Kidney CancerP50CA196516 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Payal Kapur, Payal Kapur · 2016 to 2026
$24.7M
Developmental transcription factors in Drosha-driven cancerR01CA289259 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Kenneth Sung-Man Chen · 2024 to 2026
$2.2M
The role of PLAG1 in Wilms tumor formationK08CA207849 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CHEN, KENNETH SUNG-MAN · 2017 to 2021
$781k
Functional Proteomics by Reverse Phase Protein Array in CancerR50CA221675 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LU, YILING · 2017 to 2021
$726k
Laser Scanning Confocal for UT Southwestern Live Cell Imaging FacilityS10OD021684 · OD · UT SOUTHWESTERN MEDICAL CENTER · PI LUBY-PHELPS, KATHERINE J · 2016 to 2016
$455k
NCI NIH HHS K08 CA207849NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA142543NCI NIH HHS P50 CA196516NCI NIH HHS R01 CA289259NCI NIH HHS R50 CA221675NIH HHS S10 OD021684
6 · The paper itself

Abstract

Inhibition of immune checkpoint proteins is effective in adult cancers but has shown limited efficacy in pediatric cancers. While factors regulating expression of immune checkpoint proteins such as PD-L1 are well-documented in adult cancers, their regulation is poorly understood in pediatric cancers. Here, we show that PD-L1 is upregulated in distinct subsets of Wilms tumor, the most common pediatric kidney cancer. Specifically, chemotherapy-exposed Wilms tumor specimens exhibited higher levels of PD-L1 expression, and common chemotherapeutics upregulated PD-L1 in childhood cancer cell lines

Identifiers

PMID39677784
PMCPMC11642745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.